Waldenstrom's macroglobulinaemia: A prospective study comparing daily intermittent oral chlorambucil

British Journal of Haematology

Volumn 108, Issue 4, 2000, Pages 737-742

  Kyle, Robert A ^a,b   Greipp, Philip R ^a   Gertz, Morie A ^a   Witzig, Thomas E ^a   Lust, John A ^a   Lacy, Martha Q ^a   Therneau, Terry M ^b  

^a Div of Gastroenterol and Int Med   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Chlorambucil; Monoclonal protein; Waldenstrom's macroglobulinaemia

Indexed keywords

CHLORAMBUCIL; HEMOGLOBIN; IMMUNOGLOBULIN M; RITUXIMAB; IMMUNOGLOBULIN; M PROTEINS (MYELOMA); M-PROTEINS (MYELOMA); PLASMA PROTEIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; LYMPHADENOPATHY; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WALDENSTROEM MACROGLOBULINEMIA; AGED; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DRUG ADMINISTRATION; LEUKOCYTE COUNT; METABOLISM; MIDDLE AGED; MORTALITY; SURVIVAL RATE; THROMBOCYTE COUNT; URINE;

AGED; BLOOD PROTEINS; CHI-SQUARE DISTRIBUTION; CHLORAMBUCIL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOGLOBINS; HUMANS; IMMUNOGLOBULINS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PLATELET COUNT; SURVIVAL RATE; WALDENSTROM MACROGLOBULINEMIA;

EID: 0033625584     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.01918.x     Document Type: Article

References (17)

1. Bayrd, E.D. (1961) Continuous chlorambucil therapy in primary macroglobulinemia of Waldenström: report of four cases. Proceedings of the Staff Meetings of the Mayo Clinic, 36, 135-147.
2. Bouroncle, B.A., Datta, P. & Frajola, W.J. (1964) Waldenström's macroglobulinemia: report of three patients treated with cyclophosphamide. Journal of the American Medical Association, 189, 729-732.
3. Byrd, J.C., White, C.A., Link, B., Thomas, S., Valasquez, W.S., Rosenberg, J. & Grillo-Lopez, A.J. (1998) Rituximab therapy in previously treated Waldenstrom's macroglobulinemia: preliminary evidence of activity (Abstract). Blood, 92, 106a.
4. Case, Jr. D.C., Ervin, T.J., Boyd, M.A. & Redfield, D.L. (1991) Waldenström's macroglobulinemia: long-term results of the M-2 protocol. Cancer Investigations, 9, 1-7.
5. Delannoy, A., Ferrant, A., Martiat, P., Bosly, A., Zenebergh, A. & Michaux, J.L. (1994) 2-Chlorodeoxyadenosine therapy in Waldenström's macroglobulinaemia. Nouvelle Revue Française d'Hématologie, 36, 317-320.
6. Dhodapkar, M., Jacobson, J., Gertz, M., Crowley, J., Shurata, M., Salmon, S., Kyle, R. & Barlogie, B. (1997) Phase II intergroup trial of fludarabine (FAMP) in Waldenström's macroglobulinemia (WM): results of Southwest Oncology Group trial (SWOG 9003) in 220 patients (Abstract). Blood, 90, 577a.
7. Dimopoulos, M.A. & Alexanian, R. (1994) Waldenström's macroglobulinemia. Blood, 83, 1452-1459.
8. Dimopoulos, M.A., Weber, D.M., Kantarjian, H., Keating, M. & Alexanian, R. (1994a) 2-Chlorodeoxyadenosine therapy of patients with Waldenström's macroglobulinemia previously treated with fludarabine. Annals of Oncology, 5, 288-289.
9. Dimopoulos, M.A., Luckett, R. & Alexanian, R. (1994b) Primary therapy of Waldenström's macroglobulinemia with paclitaxel (Letter). Journal of Clinical Oncology, 12, 1998.
10. Dimopoulos, M.A., Weber, D., Delasalle, K.B., Keating, M. & Alexanian, R. (1995) Treatment of Waldenström's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: identification of prognostic factors. Annals of Oncology, 6, 49-52.
11. Dreger, P., Glass, B., Kuse, R., Sonnen, R., von Neuhoff, N., Bolouri, H., Kneba, M. & Schmitz, N. (1999) Myeloablative radiochemotherapy followed by reinfusion of purged autologous stem cells for Waldenström's macroglobulinaemia. British Journal of Haematology, 106, 115-118.
12. Foran, J.M., Rohatiner, A.Z.S., Coiffier, B., Barbui, T., Johnson, S.A., Hiddemann, W., Radford, J.A., Norton, A.J., Tollerfield, S.M., Wilson, M.P. & Lister, T.A. (1999) Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and Mantle-cell lymphoma. Journal of Clinical Oncology, 17, 546-553.
13. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B. & Gatter, K.C. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361-1392.
14. Jaffe, E.S. (1998) Histopathology of the non-Hodgkin's lymphomas and Hodgkin's disease. The Lymphomas (ed. by G.P. Canellos, T.A. Lister & J.L. Sklar). pp. 77-106. W.B. Saunders, Philadelphia.
15. Leblond, V., Ben-Othman, T., Deconinck, E., Taksin, A.-L., Harousseau, J.-L., Delgado, M.A., Delmer, A., Maloisel, F., Mariette, X., Morel, P., Clauvel, J.-P., Duboisset, P., Entezam, S., Hermine, O., Merlet, M., Yakoub-Agha, I., Guibon, O., Caspard, H. & Fort, N. (1998) Activity of fludarabine in previously treated Waldenström's macroglobulinemia: a report of 71 cases. Journal of Clinical Oncology, 16, 2060-2064.
16. Liu, E.S., Burian, C., Miller, W.E. & Saven, A. (1998) Bolus administration of cladribine in the treatment of Waldenström's macroglobulinaemia. British Journal of Haematology, 103, 690-695.
17. Petrucci, M.T., Avvisati, G., Tribalto, M., Giovangrossi, P. & Mandelli, F. (1989) Waldenström's macroglobulinaemia: results of a combined oral treatment in 34 newly diagnosed patients. Journal of Internal Medicine, 226, 443-447.